In this panel discussion, explore career paths in STEM without the need for a Ph.D.

About this Event

Have you ever wondered what career avenues are available for those who want to work in STEM but may not want to take the traditional route of obtaining a Ph.D.?

Women Accelerators next round table panel discussion will explore just that! 

Join in our informative conversation with a panel of women leaders in STEM who broke boundaries without having a Ph.D.!

Our panelists will be answering questions:

  1.  relating to their decision(s) to pursue an atypical career path,
  2. how to juggle the demands of leadership positions while being a full-time mother,
  3. and how to go about leveraging your skills to create a successful career within the STEM arena!

Get to know our panelists by reading their bio’s below, follow them on Linkedin, and come prepared with questions!

****

Panel Speakers:

Edyta Tyminski

Edyta Tyminski held the position of Senior Scientist while working at Centers for Therapeutic Innovation (CTI) Pfizer, Inc., the first-of-its-kind industry and academia drug discovery and development collaboration. Edyta occupied this position for 7 years. In this capacity, Edyta supported multiple drug discovery projects culminating with 3 different Development Candidates (DC) nominations.

Currently, Edyta is employed as Principal Scientist by Jnana Therapeutics, Inc., a privately-held biotech start-up that is pioneering the development of small molecule drugs that target the SLC (solute carrier) family of metabolite transporters, which are key regulators of cellular metabolism. Edyta joined Jnana Therapeutics in 2018 as number 13 employee and has helped the company to expand to more than 50 people right now.

Born and raised in Poland Edyta obtained BS, MS and MBA degrees all from the University of Massachusetts public school system.

–> Linkedin profile

Jennifer Christensen, MS

Jennifer Christensen is the Vice President and Medicine Development Lead for niraparib (Zejula) for ovarian cancer, at GlaxoSmithKline (GSK).

Jennifer has more than 15 years of experience as a scientist and leader on global development teams for oncology. She has broad experience leading programs from product acquisition through registration, to commercialization and/or out-licensing.

At the start of her professional career, Jennifer worked at the bench as a research associate for Berlex Pharmaceuticals where she focused on medicinal and bioanalytical chemistry for a radiopharmaceutical therapy platform, formulation development and conducted PK/biodistribution studies to support compound screening.

In 2011, Jennifer was one of the first employees to join TESARO and following the acquisition of TESARO, Jennifer became a GSK associate to continue to lead the Zejula Medicine Development Team (MDT) for the ovarian cancer indication. Under her leadership, Zejula was initially approved for maintenance treatment of recurrent ovarian cancer for all patients regardless of biomarker status. In 2020, GSK announced that the US Food and Drug Administration and the European Commission approved Zejula for first-line maintenance treatment of ovarian cancer in US and EU for patients regardless of biomarker status. Jennifer supported these approvals and is responsible for expanding Global registration in key emerging markets.

Jennifer received a Master’s degree in Organic Chemistry from Brandeis University in Waltham, Mass. and a Bachelor’s degree in Biochemistry from Saint Anselm College in Goffstown, NH.

–> LinkedIn profile

Linkedin:

Keri Mattaliano, MLIS

Keri Mattaliano is a librarian that builds software for librarians. As Director of Corporate Solutions for Copyright Clearance Center, Keri develops go-to-market strategies, conducts market research and competitive analysis, creates customer personas, and develops product positioning and tools to drive demand for information management tools for R&D-intensive organizations. As a subject matter expert in content and information management for corporate Life Sciences, Chemical, Energy, and Food companies, Keri makes product and business decisions to build solutions that enable research organizations to drive innovation.

Linkedin  profile

***

This seminar is open to everyone interested!

*Donations will contribute toward the enrichment of women careers and future programs*

***

Date/Time: Tuesday, June 8th, 2021, 6:00-7:30 PM

Location: This is a virtual event

***

Corporate sponsorships are available.

Email [email protected] for more information.